Bora CDMO Bora CDMO

X

Find Argatroban manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

Argatroban
Also known as: (21r)-argatroban, 121785-71-5, 0dw7mih1vx, (2r,4r)-1-[(2s)-5-(diaminomethylideneamino)-2-[[(3r)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid, Dsstox_cid_26467, Dsstox_rid_81640
Molecular Formula
C23H36N6O5S
Molecular Weight
508.6  g/mol
InChI Key
KXNPVXPOPUZYGB-XYVMCAHJSA-N
FDA UNII
0DW7MIH1VX

1 2D Structure

Argatroban

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(3R)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid
2.1.2 InChI
InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15-,17+,18-/m1/s1
2.1.3 InChI Key
KXNPVXPOPUZYGB-XYVMCAHJSA-N
2.1.4 Canonical SMILES
CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C
2.1.5 Isomeric SMILES
C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NC[C@@H](C3)C
2.2 Other Identifiers
2.2.1 UNII
0DW7MIH1VX
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (21r)-argatroban

2. (21r)-argatroban Anhydrous

3. (21s)-argatroban

4. (21s)-argatroban Anhydrous

5. (2r,4r)-1-((2s)-5-((aminoiminomethyl)amino)-1-oxo-2-((((3r)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-2-piperidinecarboxylic Acid

6. (2r,4r)-1-((2s)-5-((aminoiminomethyl)amino)-1-oxo-2-((((3s)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-2-piperidinecarboxylic Acid

7. (2r,4r)-1-(5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-2-piperidinecarboxylic Acid

8. (2r,4r)-1-(5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-2-piperidinecarboxylic Acid Monohydrate

9. Acova

10. Argatroban

11. Argatroban Anhydrous

12. Argatroban Hydrate

13. Argatroban Monohydrate

14. Mci 9038

15. Mci-9038

16. Md 805

17. Md-805

18. Md805

19. Mmtqap

20. Mpqa

21. Novastan

2.3.2 Depositor-Supplied Synonyms

1. (21r)-argatroban

2. 121785-71-5

3. 0dw7mih1vx

4. (2r,4r)-1-[(2s)-5-(diaminomethylideneamino)-2-[[(3r)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic Acid

5. Dsstox_cid_26467

6. Dsstox_rid_81640

7. Dsstox_gsid_46467

8. Cas-74863-84-6

9. Unii-0dw7mih1vx

10. Ncgc00164592-01

11. 21(r)-argatroban

12. Schembl4375

13. Bidd:gt0748

14. Chembl59461

15. 21r-argatroban Anhydrous

16. Argatroban Anhydrous, 21r-

17. Ex-a4205

18. Zinc3807172

19. Tox21_112218

20. Tox21_112218_1

21. Argatroban Anhydrous, (21r)-

22. Ncgc00166413-02

23. 2-piperidinecarboxylic Acid, 1-(5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-, (2r-(1(s*(r*)),2alpha,4beta))-

24. Q474880

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 508.6 g/mol
Molecular Formula C23H36N6O5S
XLogP31.3
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count8
Rotatable Bond Count9
Exact Mass508.24678944 g/mol
Monoisotopic Mass508.24678944 g/mol
Topological Polar Surface Area189 Ų
Heavy Atom Count35
Formal Charge0
Complexity887
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameArgatroban
PubMed HealthArgatroban (Injection)
Drug ClassesAnticoagulant
Drug LabelArgatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8- quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has...
Active IngredientArgatroban
Dosage FormInjectable
Routeinjection; Injection
Strength250mg/250ml; 100mg; 250mg/2.5ml (100mg/ml)
Market StatusTentative Approval; Prescription
CompanyPar Sterile Products; Baxter Hlthcare; Mylan Institutional; Pliva Hrvatska Doo; Hikma Pharm

2 of 2  
Drug NameArgatroban
PubMed HealthArgatroban (Injection)
Drug ClassesAnticoagulant
Drug LabelArgatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8- quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has...
Active IngredientArgatroban
Dosage FormInjectable
Routeinjection; Injection
Strength250mg/250ml; 100mg; 250mg/2.5ml (100mg/ml)
Market StatusTentative Approval; Prescription
CompanyPar Sterile Products; Baxter Hlthcare; Mylan Institutional; Pliva Hrvatska Doo; Hikma Pharm

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antithrombins

Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. (See all compounds classified as Antithrombins.)


Platelet Aggregation Inhibitors

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)


left grey arrow
right gray arrow
  • INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML)
  • INJECTABLE;INJECTION - 50MG/50ML (1MG/ML)
  • INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML)
  • INJECTABLE;INTRAVENOUS - 50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • INJECTABLE;INTRAVENOUS - 125MG/125ML (1MG/ML)
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY